Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 15, 2006 (Vol. 26, No. 10)

Inhibiting Protein-Protein Interactions

Finding Real Associations and Small Molecule Starting Points on the New Therapeutic Frontier

  • Recombinant therapeutic proteins are a rapidly growing category of the prescription drug market, with sales projected to reach $50 billion worldwide by 2010, according to BCC Research. These products, especially antibodies, tend to be highly specific for their targets and possess a long half-life in serum. Yet they ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.